{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:13:03Z","timestamp":1762643583431,"version":"build-2065373602"},"reference-count":251,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.rcsop.2024.100538","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T12:22:58Z","timestamp":1731154978000},"page":"100538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A scoping review of motor vehicle operator performance assessments for benzodiazepine receptor agonists"],"prefix":"10.1016","volume":"16","author":[{"given":"Andrea L.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Korolos","family":"Sawires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie M.","family":"Peltekian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Helwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Martin-Misener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bandana","family":"Saini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Neyedli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Giacomantonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2024.100538_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1478-7954-4-15","article-title":"Hypnotic use in a population-based sample of over thirty-five thousand interviewed Canadians","volume":"4","author":"Kassam","year":"2006","journal-title":"Popul Health Metrics"},{"key":"10.1016\/j.rcsop.2024.100538_bb0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.rcsop.2024.100538_bb0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.healthpol.2010.03.008","article-title":"Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use","volume":"97","author":"Cunningham","year":"2010","journal-title":"Health Policy Amst Neth"},{"key":"10.1016\/j.rcsop.2024.100538_bb0020","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/jgs.15292","article-title":"Benzodiazepine use in older adults in the United States, Ontario, and Australia from 2010 to 2016","volume":"66","author":"Brett","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.rcsop.2024.100538_bb0025","doi-asserted-by":"crossref","first-page":"E208","DOI":"10.9778\/cmajo.20130076","article-title":"Use of benzodiazepines and related drugs in Manitoba: a population-based study","volume":"2","author":"Alessi-Severini","year":"2014","journal-title":"CMAJ Open"},{"key":"10.1016\/j.rcsop.2024.100538_bb0030","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","article-title":"Long-term use of benzodiazepines: Definitions, prevalence and usage patterns \u2013 a systematic review of register-based studies","volume":"30","author":"Kurko","year":"2015","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.rcsop.2024.100538_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.19029","article-title":"Incidence of and Characteristics Associated With Long-term Benzodiazepine Use in Finland","volume":"3","author":"Taipale","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.rcsop.2024.100538_bb0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1176\/appi.ps.201800321","article-title":"Benzodiazepine Use and Misuse Among Adults in the United States","volume":"70","author":"Maust","year":"2019","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.rcsop.2024.100538_bb0045","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-244X-14-S1-S1","volume":"14","author":"Katzman","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.rcsop.2024.100538_bb0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/M15-2175","article-title":"for the clinical guidelines committee of the american college of physicians, management of chronic insomnia disorder in adults: A clinical practice guideline from the American College of Physicians","volume":"165","author":"Qaseem","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb0055","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jamainternmed.2013.3795","article-title":"Nonbenzodiazepine sleep medication use and hip fractures in nursing home residents","volume":"173","author":"Berry","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb0060","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2125.2007.02861.x","article-title":"Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey","volume":"64","author":"Victorri-Vigneau","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0065","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3233\/JAD-151006","article-title":"Regular benzodiazepine and Z-substance use and risk of dementia: An analysis of German Claims Data","volume":"54","author":"Gomm","year":"2016","journal-title":"J Alzheimers Dis JAD"},{"key":"10.1016\/j.rcsop.2024.100538_bb0070","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/pds.4028","article-title":"The association between benzodiazepines and influenza-like illness-related pneumonia and mortality: a survival analysis using UK Primary Care data","volume":"25","author":"Nakafero","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.rcsop.2024.100538_bb0075","first-page":"163","article-title":"In the Zzz zone: the effects of Z-drugs on human performance and driving","volume":"9","author":"Gunja","year":"2013","journal-title":"J Med Toxicol Off J Am Coll Med Toxicol"},{"year":"2010","series-title":"Drugs and Driving","author":"OECD","key":"10.1016\/j.rcsop.2024.100538_bb0080"},{"year":"2018","series-title":"Psychological and pharmacological treatments for adults with posttraumatic stress disorder: a systematic review update","author":"Forman-Hoffman","key":"10.1016\/j.rcsop.2024.100538_bb0085"},{"key":"10.1016\/j.rcsop.2024.100538_bb0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.rcsop.2024.100538_bb0095","first-page":"39","article-title":"Policies for deprescribing: an international scan of intended and unintended outcomes of limiting sedative-hypnotic use in community-dwelling older adults","volume":"14","author":"Shaw","year":"2019","journal-title":"Healthc Policy Polit Sante"},{"key":"10.1016\/j.rcsop.2024.100538_bb0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13012-022-01206-7","article-title":"Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework","volume":"17","author":"Evrard","year":"2022","journal-title":"Implement Sci"},{"key":"10.1016\/j.rcsop.2024.100538_bb0105","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40266-018-0544-4","article-title":"Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients","volume":"35","author":"Ng","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.rcsop.2024.100538_bb0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use: a meta-analysis","volume":"18","author":"Barker","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.rcsop.2024.100538_bb0115","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.sleep.2007.11.011","article-title":"Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam","volume":"9","author":"Gustavsen","year":"2008","journal-title":"Sleep Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb0120","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.2146\/ajhp160381","article-title":"Benzodiazepine use and cognitive decline in the elderly","volume":"75","author":"Picton","year":"2018","journal-title":"Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm"},{"key":"10.1016\/j.rcsop.2024.100538_bb0125","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1365-2125.2012.04279.x","article-title":"A European approach to categorizing medicines for fitness to drive: outcomes of the DRUID project","volume":"74","author":"Ravera","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0130","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/gerona\/gly283","article-title":"Coprescribing of benzodiazepines and opioids in older adults: rates, correlates, and national trends","volume":"74","author":"Rhee","year":"2019","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.rcsop.2024.100538_bb0135","doi-asserted-by":"crossref","first-page":"553","DOI":"10.15288\/jsad.2021.82.553","article-title":"The combined effects of alcohol and benzodiazepines on driving-related neurocognitive skills: a systematic review","volume":"82","author":"Aitken","year":"2021","journal-title":"J Stud Alcohol Drugs"},{"author":"Department of Justice","key":"10.1016\/j.rcsop.2024.100538_bb0140"},{"year":"2014","series-title":"Driving under the influence of non-alcohol drugs","author":"Norwegian Ministry of Transport and Communications","key":"10.1016\/j.rcsop.2024.100538_bb0145"},{"year":"2019","series-title":"Zopiclone, Hypnotic-Sedative, CPhA Monograph, RxTx","author":"Canadian Pharmacists Association","key":"10.1016\/j.rcsop.2024.100538_bb0150"},{"year":"2022","series-title":"Patient Medication Information: Pr IMOVANE\u00ae, zopiclone, Hypnotic-Sedative, CPS Myrxtx","author":"sanofi-aventis Canada Inc","key":"10.1016\/j.rcsop.2024.100538_bb0155"},{"year":"2022","series-title":"PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION Pr IMOVANE\u00ae Zopiclone Tablets, 5.0 mg and 7.5 mg, Oral Administration Hypnotic and Sedative","author":"sanofi-aventis Canada Inc","key":"10.1016\/j.rcsop.2024.100538_bb0160"},{"year":"2019","series-title":"Kroll Care: Apo-Lorazepam 1mg (DIN: 00655759)","author":"First Databank Inc","key":"10.1016\/j.rcsop.2024.100538_bb0165"},{"key":"10.1016\/j.rcsop.2024.100538_bb0175","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1186\/s13104-018-3869-5","article-title":"A simulated patient evaluation of pharmacist\u2019s performance in a men\u2019s mental health program","volume":"11","author":"Murphy","year":"2018","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.rcsop.2024.100538_bb0180","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11096-011-9482-5","article-title":"How do pharmacists respond to complaints of acute insomnia? A simulated patient study","volume":"33","author":"Kippist","year":"2011","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.rcsop.2024.100538_bb0185","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1177\/0300060519838953","article-title":"Do pharmacists counsel customers about the effects of sedating antihistamines on driving skills? A survey of community pharmacies in Saudi Arabia","volume":"47","author":"Khojah","year":"2019","journal-title":"J Int Med Res"},{"key":"10.1016\/j.rcsop.2024.100538_bb0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.sapharm.2016.12.010","article-title":"Pharmacists\u2019 perceptions and communication of risk for alertness impairing medications","volume":"14","author":"Jomaa","year":"2018","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.rcsop.2024.100538_bb0195","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.sapharm.2018.12.007","article-title":"Benzodiazepine use risk: Understanding patient specific risk perceptions and medication beliefs","volume":"15","author":"Sake","year":"2019","journal-title":"Res Soc Adm Pharm"},{"year":"2009","series-title":"J.C. Joris C. Verster, Drugs, driving, and traffic safety, Basel; Boston\u00a0: Birkhauser, Basel; Boston","key":"10.1016\/j.rcsop.2024.100538_bb0200"},{"key":"10.1016\/j.rcsop.2024.100538_bb0205","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hup.2406","article-title":"Excursions out-of-lane versus standard deviation of lateral position as outcome measure of the on-the-road driving test","volume":"29","author":"Verster","year":"2014","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0210","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3390\/ijerph6031041","article-title":"Psychoactive medication and traffic safety","volume":"6","author":"Verster","year":"2009","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.rcsop.2024.100538_bb0215","doi-asserted-by":"crossref","first-page":"242","DOI":"10.11124\/JBISRIR-D-19-00420","article-title":"Driving performance assessments for benzodiazepine receptor agonist\u2013related impairment: a scoping review protocol","volume":"19","author":"Murphy","year":"2021","journal-title":"JBI Evid Synth"},{"key":"10.1016\/j.rcsop.2024.100538_bb0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/XEB.0000000000000050","article-title":"Guidance for conducting systematic scoping reviews","volume":"13","author":"Peters","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"10.1016\/j.rcsop.2024.100538_bb0225","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and ExplanationThe PRISMA-ScR Statement","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.rcsop.2024.100538_bb0235","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.rcsop.2024.100538_bb0240","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1573400054065613","article-title":"Is it safe to drive a car when treated with anxiolytics? Evidence from on-the-road driving studies during normal traffic","volume":"1","author":"Verster","year":"2005","journal-title":"Curr Psychiatr Rev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0245","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/157488611798280933","article-title":"Zopiclone as positive control in studies examining the residual effects of hypnotic drugs on driving ability","volume":"6","author":"Verster","year":"2011","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.rcsop.2024.100538_bb0250","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.smrv.2012.05.004","article-title":"Blood drug concentrations of benzodiazepines correlate poorly with actual driving impairment","volume":"17","author":"Verster","year":"2013","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0255","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.aap.2011.09.003","article-title":"The prevalence and nature of stopped on-the-road driving tests and the relationship with objective performance impairment","volume":"45","author":"Verster","year":"2012","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0260","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/1574886309666140601210422","article-title":"Middle-of-the-night administration of sleep medication: a critical review of the effects on next morning driving ability","volume":"9","author":"Verster","year":"2014","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.rcsop.2024.100538_bb0265","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.smrv.2004.02.001","article-title":"Residual effects of sleep medication on driving ability","volume":"8","author":"Verster","year":"2004","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0270","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/157488606775252674","article-title":"Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test","volume":"1","author":"Verster","year":"2006","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.rcsop.2024.100538_bb0275","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/ijnp\/pyab031","article-title":"Driving performance under treatment of most frequently prescribed drugs for mental disorders: a systematic review of patient studies","volume":"24","author":"Brunnauer","year":"2021","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0280","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2165\/11539050-000000000-00000","article-title":"Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence","volume":"34","author":"Dassanayake","year":"2011","journal-title":"Drug Saf"},{"key":"10.1016\/j.rcsop.2024.100538_bb0285","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.aap.2012.06.017","article-title":"Risk of road accident associated with the use of drugs: a systematic review and meta-analysis of evidence from epidemiological studies","volume":"60","author":"Elvik","year":"2013","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0290","doi-asserted-by":"crossref","first-page":"zpab010","DOI":"10.1093\/sleepadvances\/zpab010","article-title":"Comparison of the effect of lemborexant and other insomnia treatments on driving performance: a systematic review and meta-analysis","volume":"2","author":"McElroy","year":"2021","journal-title":"SLEEP Adv"},{"key":"10.1016\/j.rcsop.2024.100538_bb0295","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/00325481.2020.1823724","article-title":"Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials","volume":"133","author":"Moline","year":"2021","journal-title":"Postgrad Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb0300","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/pds.1763","article-title":"The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies","volume":"18","author":"Orriols","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.rcsop.2024.100538_bb0305","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.08m04325","article-title":"Benzodiazepine use and driving: a meta-analysis","volume":"70","author":"Rapoport","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rcsop.2024.100538_bb0310","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/15389588.2013.830211","article-title":"Meta-Analysis of On-the-Road Experimental Studies of Hypnotics: Effects of Time After Intake, Dose, and Half-Life","volume":"15","author":"Roth","year":"2014","journal-title":"Traffic Inj Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0315","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.aap.2016.08.001","article-title":"Medication use and the risk of motor vehicle collisions among licensed drivers: A systematic review","volume":"96","author":"Rudisill","year":"2016","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0320","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2165\/11533170-000000000-00000","article-title":"The Relationship between Benzodiazepine Use and Traffic Accidents: A Systematic Literature Review","volume":"24","author":"Smink","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.rcsop.2024.100538_bb0325","first-page":"799","article-title":"Benzodiazepine use and motor vehicle accidents. Systematic review of reported association","volume":"44","author":"Thomas","year":"1998","journal-title":"Can Fam Physician Med Fam Can"},{"key":"10.1016\/j.rcsop.2024.100538_bb0330","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/030006057400200301","article-title":"Effects of oxypertine and chlordiazepoxide on human motor coordination","volume":"2","author":"Berry","year":"1974","journal-title":"J Int Med Res"},{"key":"10.1016\/j.rcsop.2024.100538_bb0335","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/02698811030173015","article-title":"Do zopiclone, zolpidem and flunitrazepam have residual effects on simulated task of collision anticipation?","volume":"17","author":"Berthelon","year":"2003","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"10.1016\/j.rcsop.2024.100538_bb0340","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/bmj.4.5840.580","article-title":"Effects of four commonly-used tranquillizers on low-speed driving performance tests","volume":"4","author":"Betts","year":"1972","journal-title":"Br Med J"},{"key":"10.1016\/j.rcsop.2024.100538_bb0345","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/bmj.285.6345.852","article-title":"Effect of two hypnotic drugs on actual driving performance next morning","volume":"285","author":"Betts","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"suppl 1","key":"10.1016\/j.rcsop.2024.100538_bb0350","first-page":"85S","article-title":"Studies of clobazam and car-driving","volume":"7","author":"Biehl","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0355","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00213-010-2075-5","article-title":"Zolpidem and zopiclone impair similarly monotonous driving performance after a single nighttime intake in aged subjects","volume":"214","author":"Bocca","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0360","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s002130050961","article-title":"Residual effects of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades","volume":"143","author":"Bocca","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0365","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hup.936","article-title":"Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone","volume":"23","author":"Boyle","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0370","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02657065","article-title":"Repeated dose effects of lormetazepam and flurazepam upon driving performance","volume":"39","author":"Brookhuis","year":"1990","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0375","first-page":"23","article-title":"Alcohol, drugs and driving: implications for evaluating driver impairment","volume":"57","author":"Brown","year":"2013","journal-title":"Ann Adv Automot Med Assoc Adv Automot Med Annu Sci Conf"},{"key":"10.1016\/j.rcsop.2024.100538_bb0380","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1080\/15389588.2017.1378814","article-title":"Evaluating drugged driving: Effects of exemplar pain and anxiety medications","volume":"19","author":"Brown","year":"2018","journal-title":"Traffic Inj Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0385","article-title":"Effects of one month of nightly zopiclone on obstructive sleep apnea severity and symptoms: A randomized, double-blind, placebo-controlled trial","volume":"195","author":"Carter","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2020.02.057","article-title":"Randomized trial on the effects of high-dose zopiclone on osa severity, upper airway physiology, and alertness","author":"Carter","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.rcsop.2024.100538_bb0395","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.aap.2013.08.004","article-title":"Lorazepam impairs highway driving performance more than heavy alcohol consumption","volume":"60","author":"Daurat","year":"2013","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0400","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF00426462","article-title":"Psychomotor performance and real driving performance of outpatients receiving diazepam","volume":"73","author":"de Gier","year":"1981","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0405","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00421465","article-title":"Clinical and experimental comparison of diazepam, chlorazepate and placebo","volume":"40","author":"Dureman","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.rcsop.2024.100538_bb0410","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00426875","article-title":"Comparison studies of chlorazepate administered as a divided daily dose and as a single dose at night","volume":"57","author":"Dureman","year":"1978","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0415","first-page":"15","article-title":"Testing drivers taking diazepam in the Daimler-Benz driving simulator","volume":"19","author":"Friedel","year":"1991","journal-title":"J Traffic Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb0420","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2125.1977.tb00788.x","article-title":"Clobazam, a 1,5-benzodiazepine, and car-driving ability","volume":"4","author":"Hindmarch","year":"1977","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0425","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2125.1980.tb01731.x","article-title":"The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability","volume":"10","author":"Hindmarch","year":"1980","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0430","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00213-005-0172-7","article-title":"A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers","volume":"183","author":"Hindmarch","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0435","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/0269881119836198","article-title":"Evaluation of simulated driving in comparison to laboratory-based tests to assess the pharmacodynamics of alprazolam and alcohol","volume":"33","author":"Huizinga","year":"2019","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"10.1016\/j.rcsop.2024.100538_bb0440","doi-asserted-by":"crossref","first-page":"304","DOI":"10.5414\/CPP40304","article-title":"Lormetazepam effects on daytime vigilance, psychomotor performance and simulated driving in young adult healthy volunteers","volume":"40","author":"Iudice","year":"2002","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.rcsop.2024.100538_bb0445","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00213-022-06075-y","article-title":"Residual effects of zopiclone on driving performance using a standardized driving simulator among healthy volunteers","volume":"239","author":"Iwamoto","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0450","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00213-018-4844-5","article-title":"Comparing the effects of oxazepam and diazepam in actual highway driving and neurocognitive test performance: a validation study","volume":"235","author":"Jongen","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0455","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hup.2530","article-title":"Next-day residual effects of gabapentin, diphenhydramine, and triazolam on simulated driving performance in healthy volunteers: a phase 3, randomized, double-blind, placebo-controlled, crossover trial","volume":"31","author":"Kay","year":"2016","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0460","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2603","article-title":"Next-day residual effects of flibanserin on simulated driving performance in premenopausal women","volume":"32","author":"Kay","year":"2017","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0465","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-0773.1994.tb00329.x","article-title":"Drug and ethanol effects on the clinical test for drunkenness: single doses of ethanol, hypnotic drugs and antidepressant drugs","volume":"75","author":"Kuitunen","year":"1994","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0470","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1600-0773.1986.tb00092.x","article-title":"The carry-over effects of triazolam compared with nitrazepam and placebo in acute emergency driving situations and in monotonous simulated driving","volume":"58","author":"Laurell","year":"1986","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"10.1016\/j.rcsop.2024.100538_bb0475","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00213-006-0669-8","article-title":"Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg","volume":"191","author":"Leufkens","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0480","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/JCP.0b013e3181b57b43","article-title":"Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo","volume":"29","author":"Leufkens","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0485","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2869.2009.00746.x","article-title":"Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem","volume":"18","author":"Leufkens","year":"2009","journal-title":"J Sleep Res"},{"key":"10.1016\/j.rcsop.2024.100538_bb0490","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.clinthera.2013.11.005","article-title":"Zopiclone\u2019s residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies","volume":"36","author":"Leufkens","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.rcsop.2024.100538_bb0495","first-page":"2851","article-title":"On-the-road driving performance and driving-related skills in older untreated insomnia patients and chronic users of hypnotics","volume":"231","author":"Leufkens","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0500","first-page":"2785","article-title":"Residual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study","volume":"231","author":"Leufkens","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0505","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0028-1094375","article-title":"Proceedings: Drug interaction on driving skills as evaluated by laboratory tests and by a driving simulator","volume":"6","author":"Linnoila","year":"1973","journal-title":"Pharmakopsychiatr Neuropsychopharmakol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0510","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/cpt1974154368","article-title":"Effects of diazepam and codeine, alone and in combination with alcohol, on simulated driving","volume":"15","author":"Linnoila","year":"1974","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.rcsop.2024.100538_bb0515","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2125.1993.tb05694.x","article-title":"Diazepam effects on the performance of healthy subjects are not enhanced by treatment with the antihistamine ebastine","volume":"35","author":"Mattila","year":"1993","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0520","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00192551","article-title":"Suriclone enhances the actions of chlorpromazine on human psychomotor performance but not on memory or plasma prolactin in healthy subjects","volume":"46","author":"Mattila","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0525","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0091-3057(97)00506-6","article-title":"Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory","volume":"59","author":"Mattila","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.rcsop.2024.100538_bb0530","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2165\/00044011-199917060-00005","article-title":"Comparative study of the effects of captodiamine and lorazepam on car driving ability","volume":"17","author":"Mercier-Guyon","year":"1999","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.rcsop.2024.100538_bb0535","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00213-009-1677-2","article-title":"Residual effects of hypnotic drugs in aging drivers submitted to simulated accident scenarios: an exploratory study","volume":"207","author":"Meskali","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0540","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.5665\/SLEEP.1272","article-title":"Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects","volume":"34","author":"Mets","year":"2011","journal-title":"Sleep"},{"key":"10.1016\/j.rcsop.2024.100538_bb0545","article-title":"The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers","author":"Miyata","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0550","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jpsychires.2020.10.028","article-title":"Silexan does not affect driving performance after single and multiple dose applications: Results from a double-blind, placebo and reference-controlled study in healthy volunteers","volume":"136","author":"Moller","year":"2021","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.rcsop.2024.100538_bb0555","first-page":"45","article-title":"Effects of chronically administered buspirone and diazepam on driving-related skills performance","volume":"43","author":"Moskowitz","year":"1982","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rcsop.2024.100538_bb0560","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.aap.2014.02.009","article-title":"Naturalistic conversation improves daytime motorway driving performance under a benzodiazepine: a randomised, crossover, double-blind, placebo-controlled study","volume":"67","author":"Motak","year":"2014","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0565","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.2592","article-title":"Driving performance after bedtime administration of daridorexant, assessed in a sensitive simulator","author":"Muehlan","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.rcsop.2024.100538_bb0570","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1126\/science.7089544","article-title":"Diazepam impairs lateral position control in highway driving","volume":"217","author":"O\u2019Hanlon","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.rcsop.2024.100538_bb0575","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0447.1986.tb08985.x","article-title":"Hypnotics and actual driving performance","volume":"74","author":"O\u2019Hanlon","year":"1986","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.rcsop.2024.100538_bb0580","series-title":"Imidazopyridines Anxiety Disord. Nov. Exp. Ther","first-page":"143","article-title":"Comparison of alpidem, lorazepam, and placebo effects in a combined clinical\/psychometric study: A new approach for assessing the behavioral costs and benefits of anxiolytic drug therapy","author":"O\u2019Hanlon","year":"1993"},{"key":"10.1016\/j.rcsop.2024.100538_bb0585","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000119177","article-title":"Anxiolytics\u2019 effects on the actual driving performance of patients and healthy volunteers in a standardized test. An integration of three studies","volume":"31","author":"O\u2019Hanlon","year":"1995","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0590","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/hup.980","article-title":"Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers","volume":"23","author":"Otmani","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0595","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF00644607","article-title":"Effect of active metabolites of chlordiazepoxide and diazepam, alone or in combination with alcohol, on psychomotor skills related to driving","volume":"13","author":"Palva","year":"1978","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0600","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.sleep.2003.06.005","article-title":"Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia","volume":"4","author":"Partinen","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb0605","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00213-010-2149-4","article-title":"Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype","volume":"215","author":"Ramaekers","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0610","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/15389588.2012.682233","article-title":"Does a medicinal dose of kava impair driving? A randomized, placebo-controlled, double-blind study","volume":"14","author":"Sarris","year":"2013","journal-title":"Traffic Inj Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0615","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0447.1986.tb08987.x","article-title":"Aspects of driving after hypnotic therapy with particular reference to temazepam","volume":"74","author":"Schmidt","year":"1986","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.rcsop.2024.100538_bb0620","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000399456","article-title":"Two weeks\u2019 treatment with chlorpromazine, thioridazine, sulpiride, or bromazepam: actions and interactions with alcohol on psychomotor skills related to driving","volume":"11","author":"Seppala","year":"1976","journal-title":"Mod Probl Pharmacopsychiatry"},{"key":"10.1016\/j.rcsop.2024.100538_bb0625","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0002-9343(86)90328-1","article-title":"Effects of long-term administration of buspirone and diazepam on driver steering control","volume":"80","author":"Smiley","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb0630","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3389\/fpsyg.2015.01799","article-title":"Behavioral and neurophysiological signatures of benzodiazepine-related driving impairments","volume":"6","author":"Stone","year":"2015","journal-title":"Front Psychol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0635","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/cts.13145","article-title":"A randomized, multicenter trial assessing the effects of rapastinel compared to ketamine, alprazolam, and placebo on simulated driving performance","volume":"15","author":"Su","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.rcsop.2024.100538_bb0640","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/BF00615963","article-title":"Alprazolam and lorazepam single and multiple-dose effects on psychomotor skills and sleep","volume":"29","author":"Subhan","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0645","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hup.1105","article-title":"The effects of acute treatment with tandospirone, diazepam, and placebo on driving performance and cognitive function in healthy volunteers","volume":"25","author":"Takahashi","year":"2010","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0650","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0773.1990.tb00786.x","article-title":"Acute and carry-over effects of brotizolam compared to nitrazepam and placebo in monotonous simulated driving","volume":"67","author":"Tornros","year":"1990","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0655","first-page":"4","article-title":"Simulated driving performance of benzodiazepine users","volume":"29","author":"T\u00f6rnros","year":"2001","journal-title":"J Traffic Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb0660","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13430","article-title":"Simulated driving performance in healthy adults after night-time administration of 20 mg tasimelteon","volume":"31","author":"Torres","year":"2022","journal-title":"J Sleep Res"},{"key":"10.1016\/j.rcsop.2024.100538_bb0665","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s002280000167","article-title":"Driving under light and dark conditions: effects of alcohol and diazepam in young and older subjects","volume":"56","author":"Vanakoski","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0670","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2715","article-title":"Driving performance and neurocognitive skills of long-term users of benzodiazepine anxiolytics and hypnotics","volume":"34","author":"van der Sluiszen","year":"2019","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0675","first-page":"86","article-title":"Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients","volume":"12","author":"van Laar","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0680","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s002130000633","article-title":"Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A\/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers","volume":"154","author":"van Laar","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0685","first-page":"47","article-title":"Acute effects of zolpidem and flunitrazepam on sleep, memory and driving performance, compared to those of partial sleep deprivation and placebo","volume":"21","author":"Vermeeren","year":"1995","journal-title":"Acta Ther"},{"key":"10.1016\/j.rcsop.2024.100538_bb0690","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1002\/(SICI)1099-1077(1998110)13:2+<S98::AID-HUP54>3.0.CO;2-1","article-title":"Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance","volume":"13","author":"Vermeeren","year":"1998","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0695","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1002\/(SICI)1099-1077(1998110)13:2+<S79::AID-HUP52>3.0.CO;2-C","article-title":"Residual effects on actual car driving of evening dosing of chlorpheniramine 8 and 12 mg when use with terfenadine 60 mg in the morning","volume":"13","author":"Vermeeren","year":"1998","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1016\/j.rcsop.2024.100538_bb0700","first-page":"224","article-title":"Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol","volume":"25","author":"Vermeeren","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.rcsop.2024.100538_bb0705","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S1389-9457(11)70023-5","article-title":"Effect of middle-of-the-night doses of zolpidemsublingual tablet 3.5 mg on next-morning driving performance","volume":"12","author":"Vermeeren","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb0710","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.5665\/sleep.5168","article-title":"On-the-road driving performance the morning after bedtime use of suvorexant 20 and 40 mg: A study in non-elderly healthy volunteers","volume":"38","author":"Vermeeren","year":"2015","journal-title":"Sleep"},{"key":"10.1016\/j.rcsop.2024.100538_bb0715","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1007\/s00213-016-4375-x","article-title":"On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly","volume":"233","author":"Vermeeren","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0720","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsy260","article-title":"On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers","volume":"42","author":"Vermeeren","year":"2019","journal-title":"Sleep"},{"key":"10.1016\/j.rcsop.2024.100538_bb0725","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00004714-200212000-00007","article-title":"Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance","volume":"22","author":"Verster","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0730","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0893-133X(02)00310-X","article-title":"Effects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled study","volume":"27","author":"Verster","year":"2002","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0735","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00213-013-3236-0","article-title":"Lapses of attention as outcome measure of the on-the-road driving test","volume":"231","author":"Verster","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0740","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.12622","article-title":"Highway driving safety the day after using sleep medication: the direction of lapses and excursions out-of-lane in drowsy drivers","volume":"27","author":"Verster","year":"2018","journal-title":"J Sleep Res"},{"key":"10.1016\/j.rcsop.2024.100538_bb0745","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2778","article-title":"An explorative approach to understanding individual differences in driving performance and neurocognition in long-term benzodiazepine users","volume":"36","author":"Vinckenbosch","year":"2021","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0750","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hup.470070502","article-title":"A comparative study of on-the-road and simulated driving performance after nocturnal treatment with lormetazepam 1 mg and oxazepam 50 mg","volume":"7","author":"Volkerts","year":"1992","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0755","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00433559","article-title":"Individual and group effect of 10 mg diazepam on drivers\u2019 ability, confidence and willingness to act in a gap-judging task","volume":"63","author":"Wetherell","year":"1979","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb0760","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/00140138308963438","article-title":"Driving ability following the subchronic application of lormetazepam, flurazepam and placebo","volume":"26","author":"Willumeit","year":"1983","journal-title":"Ergonomics"},{"key":"10.1016\/j.rcsop.2024.100538_bb0765","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-2007-1017405","article-title":"Alcohol interaction of lormetazepam, mepindolol sulphate and diazepam measured by performance on the driving simulator","volume":"17","author":"Willumeit","year":"1984","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.rcsop.2024.100538_bb0770","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/978-3-642-69659-6_16","article-title":"Simulated car driving as a useful technique for the determination of residual effects and alcohol interaction after short- and long-acting benzodiazepines","volume":"1","author":"Willumeit","year":"1984","journal-title":"Psychopharmacol Suppl"},{"key":"10.1016\/j.rcsop.2024.100538_bb0775","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jflm.2016.01.018","article-title":"The prevalence of alcohol and psychotropic drugs in fatalities of road-traffic accidents in Jordan during 2008-2014","volume":"39","author":"Al-Abdallat","year":"2016","journal-title":"J Forensic Leg Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb0780","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.aap.2008.10.002","article-title":"Alcohol and drugs in fatally and non-fatally injured motor vehicle drivers in northern Sweden","volume":"41","author":"Ahlm","year":"2009","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0785","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.injury.2018.09.035","article-title":"Alcohol in combination with illicit drugs among fatal injuries in Sao Paulo, Brazil: An epidemiological study on the association between acute substance use and injury","volume":"49","author":"Andreuccetti","year":"2018","journal-title":"Injury"},{"key":"10.1016\/j.rcsop.2024.100538_bb0790","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/15389588.2021.2002853","article-title":"Road traffic deaths: A retrospective analysis (2009-2019) in the north of the Italian region Emilia Romagna","volume":"23","author":"Anzillotti","year":"2022","journal-title":"Traffic Inj Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0795","first-page":"324","article-title":"Prescription medication use as a risk factor for motor vehicle collisions: a responsibility study","volume":"27","author":"Asbridge","year":"2021","journal-title":"Inj Prev J Int Soc Child Adolesc Inj Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0800","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(98)04087-2","article-title":"Association of road-traffic accidents with benzodiazepine use","volume":"352","author":"Barbone","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.rcsop.2024.100538_bb0805","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.forsciint.2004.12.039","article-title":"Drugs in injured drivers in Denmark","volume":"150","author":"Bernhoft","year":"2005","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb0810","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0379-0738(87)90105-8","article-title":"A retrospective study of drugged driving in Norway","volume":"33","author":"Bjorneboe","year":"1987","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb0815","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/anatox\/35.6.349","article-title":"Benzodiazepine whole blood concentrations in cases with positive oral fluid on-site screening test results using the DrugWipe(R) single for benzodiazepines","volume":"35","author":"Blencowe","year":"2011","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0820","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.forsciint.2014.03.027","article-title":"Which drugs are associated with highest risk for being arrested for driving under the influence? A case-control study","volume":"240","author":"Bogstrand","year":"2014","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb0825","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.sleep.2015.12.004","article-title":"Zolpidem use and motor vehicle collisions in older drivers","volume":"20","author":"3rd Booth","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb0830","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0376-8716(02)00188-6","article-title":"Clinical impairment of benzodiazepines--relation between benzodiazepine concentrations and impairment in apprehended drivers","volume":"68","author":"Bramness","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.rcsop.2024.100538_bb0835","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00228-003-0677-0","article-title":"Testing for benzodiazepine inebriation--relationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers","volume":"59","author":"Bramness","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0840","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.forsciint.2005.06.009","article-title":"Flunitrazepam: psychomotor impairment, agitation and paradoxical reactions","volume":"159","author":"Bramness","year":"2006","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb0845","first-page":"e374","article-title":"Medications and risk of motor vehicle collision responsibility in British Columbia, Canada: a population-based case-control study., Lancet","volume":"6","author":"Brubacher","year":"2021","journal-title":"Public Health"},{"key":"10.1016\/j.rcsop.2024.100538_bb0850","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.aap.2018.10.012","article-title":"Use of multiple data sources to identify specific drugs and other factors associated with drug and alcohol screening of fatally injured motor vehicle drivers","volume":"122","author":"Bunn","year":"2019","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0855","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jflm.2012.10.005","article-title":"Concentrations of drugs determined in blood samples collected from suspected drugged drivers in England and Wales","volume":"20","author":"Burch","year":"2013","journal-title":"J Forensic Leg Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb0860","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.forsciint.2018.05.003","article-title":"Alcohol and drugs use among drivers injured in road accidents in Campania (Italy): A 8-years retrospective analysis","volume":"288","author":"Carfora","year":"2018","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb0865","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0379-0738(02)00116-0","article-title":"Alcohol, illicit drugs and medicinal drugs in fatally injured drivers in Spain between 1991 and 2000","volume":"127","author":"Carmen del Rio","year":"2002","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb0870","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1742-6723.2007.00958.x","article-title":"Drug use in motor vehicle drivers presenting to an Australian, adult major trauma centre","volume":"19","author":"Ch\u2019ng","year":"2007","journal-title":"Emerg Med Australas EMA"},{"key":"10.1016\/j.rcsop.2024.100538_bb0875","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1365-2125.2012.04410.x","article-title":"Psychotropic drugs and risk of motor vehicle accidents: a population-based case-control study","volume":"75","author":"Chang","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb0880","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0379-0738(99)00194-2","article-title":"Drugged driving in the Nordic countries--a comparative study between five countries","volume":"106","author":"Christophersen","year":"1999","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb0885","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/15389580701869190","article-title":"Frequent detection of benzodiazepines in drugged drivers in Norway","volume":"9","author":"Christophersen","year":"2008","journal-title":"Traffic Inj Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0890","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/15389588.2020.1724977","article-title":"The implementation of per-se limits for driving under the influence of benzodiazepines and related drugs: No increased risk for arrest during therapeutic use in Norway","volume":"21","author":"Christophersen","year":"2020","journal-title":"Traffic Inj Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0895","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1520\/JFS12203J","article-title":"Incidence and toxicological aspects of drugs detected in 484 fatally injured drivers and pedestrians in Ontario","volume":"27","author":"Cimbura","year":"1982","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.rcsop.2024.100538_bb0900","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0001-4575(02)00153-7","article-title":"The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes","volume":"36","author":"Drummer","year":"2004","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0905","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.forsciint.2015.12.050","article-title":"The involvement of prescribed drugs in road trauma","volume":"265","author":"Drummer","year":"2016","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.aap.2019.105389","article-title":"Odds of culpability associated with use of impairing drugs in injured drivers in Victoria, Australia","volume":"135","author":"Drummer","year":"2020","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0915","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/15389580802161943","article-title":"The impact of benzodiazepines on safe driving","volume":"9","author":"Dubois","year":"2008","journal-title":"Traffic Inj Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2021.111097","article-title":"Prevalence and concentrations of sedative-hypnotic drugs in blood of drivers involved in road traffic crashes in the Padova region of Italy - not so easy to interpret","volume":"330","author":"Favretto","year":"2022","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb0925","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40120-015-0026-0","article-title":"Concurrent use of benzodiazepines and antidepressants and the risk of motor vehicle accident in older drivers: a nested case-control Study","volume":"4","author":"Fournier","year":"2015","journal-title":"Neurol Ther"},{"key":"10.1016\/j.rcsop.2024.100538_bb0930","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1520\/JFS10511J","article-title":"Drug detection in cases of \u201cdriving under the influence,\u201d","volume":"21","author":"Garriott","year":"1976","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.rcsop.2024.100538_bb0935","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1520\/JFS10600J","article-title":"Incidence of drugs and alcohol in fatally injured motor vehicle drivers","volume":"22","author":"Garriott","year":"1977","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.rcsop.2024.100538_bb0940","first-page":"79","article-title":"Involvement of drugs in accident causation","volume":"43","author":"Gerostamoulos","year":"2000","journal-title":"Z Zagadnien Nauk Sadowych"},{"key":"10.1016\/j.rcsop.2024.100538_bb0945","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0001-4575(93)90078-B","article-title":"Incidence of alcohol and drugs in fatally injured car drivers in Norway","volume":"25","author":"Gjerde","year":"1993","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0950","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.trf.2012.11.004","article-title":"Associations between substance use among car and van drivers in Norway and fatal injury in road traffic accidents: A case-control study","volume":"17","author":"Gjerde","year":"2013","journal-title":"Transp Res Part F Traffic Psychol Behav"},{"key":"10.1016\/j.rcsop.2024.100538_bb0955","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.aap.2009.01.011","article-title":"Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers","volume":"41","author":"Gustavsen","year":"2009","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0960","first-page":"52","article-title":"Alcohol and drug consumption as casual factors in road traffic accidents in Norway","volume":"2","author":"Haffner","year":"1974","journal-title":"Jtraffic Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb0965","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/jama.1997.03550010041037","article-title":"Benzodiazepine use and the risk of motor vehicle crash in the elderly","volume":"278","author":"Hemmelgarn","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.rcsop.2024.100538_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2020.110266","article-title":"Prevalence of alcohol and other psychoactive substances in motor vehicle drivers in Spain, 2018: Cross-sectional dataset analysis with studies from 2008 and 2013","volume":"313","author":"Herrera-G\u00f3mez","year":"2020","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb0975","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.drugalcdep.2014.10.013","article-title":"Impairment due to amphetamines and benzodiazepines, alone and in combination","volume":"145","author":"Hoiseth","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.rcsop.2024.100538_bb0980","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/15389588.2016.1247209","article-title":"Prevalence and concentrations of drugs in older suspected drugged drivers","volume":"18","author":"Hoiseth","year":"2017","journal-title":"Traffic Inj Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb0985","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/bmj.281.6251.1309","article-title":"Role of drugs in traffic accidents","volume":"281","author":"Honkanen","year":"1980","journal-title":"Br Med J"},{"key":"10.1016\/j.rcsop.2024.100538_bb0990","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023563","article-title":"Association between alcohol and drug use and arrest for driving under the influence after crash involvement in a rural area of Norway: A case-control study","volume":"9","author":"Jamt","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.rcsop.2024.100538_bb0995","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086742","article-title":"The role of marital status in the association between benzodiazepines, psychotropics and injurious road traffic crashes: a register-based nationwide study of senior drivers in Sweden","volume":"9","author":"Johnell","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.rcsop.2024.100538_bb1000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2004.05.020","article-title":"High concentrations of diazepam and nordiazepam in blood of impaired drivers: association with age, gender and spectrum of other drugs present","volume":"146","author":"Jones","year":"2004","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb1005","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.forsciint.2012.05.008","article-title":"Concentrations of zolpidem and zopiclone in venous blood samples from impaired drivers compared with femoral blood from forensic autopsies","volume":"222","author":"Jones","year":"2012","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb1010","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/0269881112471155","article-title":"Concentrations of alprazolam in blood from impaired drivers and forensic autopsies were not much different but showed a high prevalence of co-ingested illicit drugs","volume":"27","author":"Jones","year":"2013","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"10.1016\/j.rcsop.2024.100538_bb1015","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/0897190012451910","article-title":"Concentrations of diazepam and nordiazepam in 1,000 blood samples from apprehended drivers--therapeutic use or abuse of anxiolytics?","volume":"26","author":"Jones","year":"2013","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.rcsop.2024.100538_bb1020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.forsciint.2012.02.006","article-title":"Phenazepam abuse in Finland: findings from apprehended drivers, post-mortem cases and police confiscations","volume":"220","author":"Kriikku","year":"2012","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb1025","first-page":"80","article-title":"Psychoactive drugs in the road traffic in the legal and consultative aspects-Experience gained by the Forensic Medicine Department, Silesian University of Medicine, Katowice","volume":"1","author":"Kulikowska","year":"2009","journal-title":"Forensic Sci Int Suppl Ser"},{"key":"10.1016\/j.rcsop.2024.100538_bb1030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1353-1131(99)90059-7","article-title":"Drugs and driving: a retrospective study of the analyses of blood and urine specimens submitted to the Lothian and Borders Police Forensic Laboratory","volume":"6","author":"Ledingham","year":"1999","journal-title":"J Clin Forensic Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb1035","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.forsciint.2012.03.006","article-title":"Prevalence of alcohol and other psychoactive substances in injured drivers: comparison between Belgium and The Netherlands","volume":"220","author":"Legrand","year":"2012","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb1040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/dta.1393","article-title":"Alcohol and drugs in seriously injured drivers in six European countries","volume":"5","author":"Legrand","year":"2013","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.rcsop.2024.100538_bb1045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/17457300.2012.748809","article-title":"Prevalence of alcohol, illicit drugs and psychoactive medicines in killed drivers in four European countries","volume":"21","author":"Legrand","year":"2014","journal-title":"Int J Inj Control Saf Promot"},{"key":"10.1016\/j.rcsop.2024.100538_bb1050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1520\/JFS14919J","article-title":"Zolpidem and driving impairment","volume":"46","author":"Logan","year":"2001","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.rcsop.2024.100538_bb1055","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0001-4575(99)00111-6","article-title":"The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part i: the prevalence of drug use in drive the drug-positive group","volume":"32","author":"Longo","year":"2000","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb1060","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0001-4575(99)00110-4","article-title":"The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part ii: the relationship between drug prevalence and drug concentration, and driver culpability","volume":"32","author":"Longo","year":"2000","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb1065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF03404852","article-title":"The additive effects of alcohol and benzodiazepines on driving","volume":"101","author":"Maxwell","year":"2010","journal-title":"Can J Public Health Rev Can Sante Publique"},{"key":"10.1016\/j.rcsop.2024.100538_bb1070","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0001-4575(94)00069-X","article-title":"Alcohol, drugs, and impairment in fatal traffic accidents in British Columbia","volume":"27","author":"Mercer","year":"1995","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb1075","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0001-4575(03)00084-8","article-title":"Psychoactive substance use and the risk of motor vehicle accidents","volume":"36","author":"Movig","year":"2004","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb1080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0379-0738(03)00052-5","article-title":"Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study","volume":"133","author":"Mura","year":"2003","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb1085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/1047-2797(94)00112-7","article-title":"Risk of traffic accident injury after a prescription for a benzodiazepine","volume":"5","author":"Neutel","year":"1995","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.rcsop.2024.100538_bb1090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/pds.2630040202","article-title":"Medical events after a prescription for a benzodiazepine","volume":"4","author":"Neutel","year":"1995","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.rcsop.2024.100538_bb1095","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1002\/(SICI)1099-1077(1998110)13:2+<S115::AID-HUP56>3.0.CO;2-O","article-title":"Benzodiazepine-related traffic accidents in young and elderly drivers","volume":"13","author":"Neutel","year":"1998","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.rcsop.2024.100538_bb1100","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40263-017-0445-9","article-title":"New, occasional, and frequent use of zolpidem or zopiclone (Alone and in Combination) and the risk of injurious road traffic crashes in older adult drivers: A population-based case-control and case-crossover study","volume":"31","author":"Nevriana","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.rcsop.2024.100538_bb1105","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-022-06146-0","article-title":"Use of psychotropic medication and risk of road traffic crashes: a registry-based case-control study in Denmark, 1996-2018","author":"Olesen","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rcsop.2024.100538_bb1110","series-title":"Psychoactive agents in traffic users in the practice of the Forensic Medicine Department, Medical Academy of Silesia, Katowice, Z Zagadnien Nauk Sadowych","first-page":"210","volume":"62","author":"Olszowy","year":"2005"},{"key":"10.1016\/j.rcsop.2024.100538_bb1115","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/02698811221080465","article-title":"Association of benzodiazepines, Z-drugs, pregabalin, and melatonin with traffic accidents: A nationwide cohort and case-crossover study in Danish adults","volume":"36","author":"Osler","year":"2022","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"10.1016\/j.rcsop.2024.100538_bb1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2019.109914","article-title":"Prevalence of therapeutic drugs in blood of drivers involved in traffic crashes in the area of Bologna, Italy","volume":"302","author":"Pelletti","year":"2019","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb1125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0376-8716(87)90076-7","article-title":"Drug findings in \u201cDriving Under the Influence of Drugs\u201d cases: a problem of illicit drug use","volume":"20","author":"Poklis","year":"1987","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.rcsop.2024.100538_bb1130","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.forsciint.2012.10.026","article-title":"The incidence of alcohol and other drugs in drivers killed in New Zealand road crashes 2004-2009","volume":"223","author":"Poulsen","year":"2012","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb1135","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/aje\/136.7.873","article-title":"Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers","volume":"136","author":"Ray","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.rcsop.2024.100538_bb1140","doi-asserted-by":"crossref","DOI":"10.1016\/j.aap.2020.105905","article-title":"The prevalence of alcohol and other drugs in fatal road crashes in Victoria, Australia","volume":"153","author":"Schumann","year":"2021","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb1145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.forsciint.2010.02.014","article-title":"First nationwide study on driving under the influence of drugs in Switzerland","volume":"198","author":"Senna","year":"2010","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb1150","first-page":"32","article-title":"A study of alcohol and drugs in impaired and fatally injured drivers in the west of Scotland","volume":"28","author":"Seymour","year":"2000","journal-title":"J Traffic Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb1155","first-page":"468","article-title":"Psychoactive substance-related deaths in road traffic accidents in Slovakia between 2000 and 2007","volume":"110","author":"Sidlo","year":"2009","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.rcsop.2024.100538_bb1160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0379-0738(95)01785-2","article-title":"Female drivers suspected for drunken or drugged driving","volume":"75","author":"Skurtveit","year":"1995","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb1165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0379-0738(01)00623-5","article-title":"Drugged drivers in Norway with benzodiazepine detections","volume":"125","author":"Skurtveit","year":"2002","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb1170","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.aap.2004.12.003","article-title":"Drug use and the severity of a traffic accident","volume":"37","author":"Smink","year":"2005","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.rcsop.2024.100538_bb1175","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jflm.2008.04.002","article-title":"The relation between the blood benzodiazepine concentration and performance in suspected impaired drivers","volume":"15","author":"Smink","year":"2008","journal-title":"J Forensic Leg Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb1180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jat\/bks080","article-title":"Phenazepam and its effects on driving","volume":"37","author":"Stephenson","year":"2013","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.rcsop.2024.100538_bb1185","first-page":"65","article-title":"Drugs of abuse in the blood of road users the experiences of the Department of Forensic Medicine at the Silesian Medical Academy in Katowice","volume":"39","author":"Sybirska","year":"1999","journal-title":"Z Zagadnien Nauk Sadowych"},{"key":"10.1016\/j.rcsop.2024.100538_bb1190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.17219\/acem\/37069","article-title":"Analysis of the prevalence of medicines and psychoactive substances among drivers in the material of the Department of Forensic Medicine at the Medical University of Bialystok","volume":"23","author":"Szeremeta","year":"2014","journal-title":"Adv Clin Exp Med Off Organ Wroclaw Med Univ"},{"key":"10.1016\/j.rcsop.2024.100538_bb1195","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4323\/rjlm.2020.50","article-title":"Drug driving in northern Greece among drivers involved in road traffic accidents","volume":"28","author":"Tsocha","year":"2020","journal-title":"Romanian J Leg Med"},{"key":"10.1016\/j.rcsop.2024.100538_bb1200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.forsciint.2017.09.010","article-title":"Toxicological findings in suspected drug-impaired drivers in Norway - Trends during 1990-2015","volume":"280","author":"Valen","year":"2017","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.rcsop.2024.100538_bb1205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2188\/jea.JE20090195","article-title":"Increased risk of hospitalization related to motor vehicle accidents among people taking zolpidem: a case-crossover study","volume":"21","author":"Yang","year":"2011","journal-title":"J Epidemiol"},{"key":"10.1016\/j.rcsop.2024.100538_bb1210","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.3399\/bjgp16X685213","article-title":"Benzodiazepine and z-hypnotic prescribing for older people in primary care: a cross-sectional population-based study","volume":"66","author":"Johnson","year":"2016","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.rcsop.2024.100538_bb1215","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.31012","article-title":"Trends in the Use of Benzodiazepines, Z-Hypnotics, and Serotonergic Drugs Among US Women and Men Before and During the COVID-19 Pandemic","volume":"4","author":"Milani","year":"2021","journal-title":"JAMA Netw Open"},{"year":"2020","series-title":"Annual Demographic Estimates: Canada, Provinces and Territories, 2020. Analysis: Total Population, Annu. Demogr. Estim. Can. Prov. Territ. 2020 Anal. Total Popul","author":"Statistics Canada","key":"10.1016\/j.rcsop.2024.100538_bb1220"},{"year":"2021","series-title":"Characterizing Prescription Benzodiazepine Use among Community-Dwelling Residents of Ontario, Canada, ODPRN","author":"Ontario Drug Policy Research Network","key":"10.1016\/j.rcsop.2024.100538_bb1225"},{"key":"10.1016\/j.rcsop.2024.100538_bb1230","doi-asserted-by":"crossref","first-page":"e877","DOI":"10.3399\/BJGP.2021.0054","article-title":"Trends in the prescription of drugs used for insomnia: an open-cohort study in Australian general practice, 2011\u20132018","volume":"71","author":"Begum","year":"2021","journal-title":"Br J Gen Pract"},{"author":"Jonah","key":"10.1016\/j.rcsop.2024.100538_bb1235"},{"author":"International Pharmaceutical Federation","key":"10.1016\/j.rcsop.2024.100538_bb1240"},{"key":"10.1016\/j.rcsop.2024.100538_bb1245","unstructured":"Australian Institute of Health and Welfare Alcohol, tobacco & other drugs in Australia: Older people, Canberra. 2024 https:\/\/www.aihw.gov.au\/reports\/alcohol\/alcohol-tobacco-other-drugs-australia\/contents\/priority-populations\/older-people [accessed February 19, 2003]."},{"key":"10.1016\/j.rcsop.2024.100538_bb1250","unstructured":"Statistics Canada Government Of Canada, Percentage of people who reported having used alcohol, cannabis, cigarettes or an illegal drug in the past year, household population aged 15 and older, Canada, 2019. 2021. https:\/\/www150.statcan.gc.ca\/n1\/daily-quotidien\/211220\/t001c-eng.htm [accessed February 19, 2023]."},{"year":"2007","series-title":"International Council on alcohol, drugs and traffic safety List Version June 26th, 2007: Categorization of system for medicinal drugs affecing driving performance","author":"Alvarez","key":"10.1016\/j.rcsop.2024.100538_bb1255"},{"key":"10.1016\/j.rcsop.2024.100538_bb1260","series-title":"Alcohol Drugs Traffic Saf. T86 Proc. 10th Int. Conf. Alcohol Drugs Traffic Saf. Amst. 9\u201312 Sept. 1986, Amsterdam\u00a0; New York\u00a0: Excerpta Medica\u00a0; New York, NY, USA\u00a0: Sole distributors for the USA and Canada, Elsevier Science Pub. Co., The Netherlands","first-page":"183","article-title":"The relationship between drivers\u2019 blood alcohol concentration (BAC) and actual driving performance during high speed travel","author":"Louwerens","year":"1987"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276624001355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276624001355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:08:01Z","timestamp":1762643281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276624001355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":251,"alternative-id":["S2667276624001355"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2024.100538","relation":{},"ISSN":["2667-2766"],"issn-type":[{"type":"print","value":"2667-2766"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A scoping review of motor vehicle operator performance assessments for benzodiazepine receptor agonists","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2024.100538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100538"}}